SG165343A1 - Jnk inhibitors for the treatment of endometriosis - Google Patents
Jnk inhibitors for the treatment of endometriosisInfo
- Publication number
- SG165343A1 SG165343A1 SG201006416-0A SG2010064160A SG165343A1 SG 165343 A1 SG165343 A1 SG 165343A1 SG 2010064160 A SG2010064160 A SG 2010064160A SG 165343 A1 SG165343 A1 SG 165343A1
- Authority
- SG
- Singapore
- Prior art keywords
- endometriosis
- treatment
- jnk inhibitors
- jnk inhibitor
- jnk
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69965805P | 2005-07-15 | 2005-07-15 | |
| EP05109447 | 2005-10-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG165343A1 true SG165343A1 (en) | 2010-10-28 |
Family
ID=35709133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG201006416-0A SG165343A1 (en) | 2005-07-15 | 2006-07-12 | Jnk inhibitors for the treatment of endometriosis |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8592414B2 (es) |
| EP (1) | EP1904181A2 (es) |
| JP (1) | JP2009509916A (es) |
| KR (1) | KR20130087052A (es) |
| AU (1) | AU2006270184B2 (es) |
| BR (1) | BRPI0613042A2 (es) |
| CA (1) | CA2611598A1 (es) |
| EA (1) | EA016437B1 (es) |
| MX (1) | MX2008000663A (es) |
| SG (1) | SG165343A1 (es) |
| WO (1) | WO2007011762A2 (es) |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3486469T2 (de) | 1983-11-02 | 1999-04-15 | Applied Research Systems Ars Holding N.V., Curacao | Herstellung heterodimirer menschlicher Fruchtbarkeitshormone |
| US4923805A (en) | 1983-11-02 | 1990-05-08 | Integrated Genetics, Inc. | Fsh |
| IT1206302B (it) | 1987-06-26 | 1989-04-14 | Serono Cesare Ist Ricerca | Ormone follicolo-stimolante urinario |
| US4988679A (en) | 1989-01-03 | 1991-01-29 | Leonard Chavkin | Liquid sustained release composition |
| IE82916B1 (en) | 1990-11-02 | 2003-06-11 | Elan Corp Plc | Formulations and their use in the treatment of neurological diseases |
| GEP20002142B (en) | 1991-01-18 | 2000-06-25 | Amgen Inc | Method for Treatment and Prevention of TNF Mediated Diseases |
| US5433951A (en) | 1993-10-13 | 1995-07-18 | Bristol-Myers Squibb Company | Sustained release formulation containing captopril and method |
| EP0727406B1 (de) | 1995-02-16 | 2001-09-05 | MERCK PATENT GmbH | Vinylenverbindungen und flüssigkristallines Medium |
| FR2762514B1 (fr) | 1997-04-29 | 1999-10-22 | Sanofi Sa | Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments pour le traitement des maladies entrainant une demyelinisation |
| SE9801474D0 (sv) | 1998-04-27 | 1998-04-27 | Active Biotech Ab | Quinoline Derivatives |
| TW591026B (en) | 1998-06-23 | 2004-06-11 | Upjohn Co | Inhibitors of alpha4beta1 mediated cell adhesion |
| BR9916223A (pt) | 1998-12-17 | 2001-09-04 | Hoffmann La Roche | 4-ariloxindóis como inibidores de cinases de proteìna jnk |
| KR20010087421A (ko) | 1998-12-17 | 2001-09-15 | 프리돌린 클라우스너, 롤란드 비. 보레르 | 4- 및 5-알키닐옥신돌과 4- 및 5-알케닐옥신돌 |
| KR100723854B1 (ko) | 1998-12-17 | 2007-05-31 | 에프. 호프만-라 로슈 아게 | 4,5-아졸로-옥신돌 |
| DE60041763D1 (de) | 1999-04-23 | 2009-04-23 | Vertex Pharma | Inhibitoren von c-jun n-terminal kinasen (jnk) |
| AU5316900A (en) | 1999-06-03 | 2000-12-28 | Vertex Pharmaceuticals Incorporated | Inhibitors of c-jun n-terminal kinases (jnk) |
| CA2381882C (en) | 1999-08-13 | 2011-01-25 | Vertex Pharmaceuticals Incorporated | Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| WO2001012609A1 (en) | 1999-08-19 | 2001-02-22 | Signal Pharmaceuticals, Inc. | Pyrazoloanthrone and derivatives thereof as jnk inhibitors and their compositions |
| EP1088822A1 (en) | 1999-09-28 | 2001-04-04 | Applied Research Systems ARS Holding N.V. | Pharmaceutically active sulfonyl hydrazide derivatives |
| EP1088821A1 (en) | 1999-09-28 | 2001-04-04 | Applied Research Systems ARS Holding N.V. | Pharmaceutically active sulfonamide derivatives |
| EP1088815A1 (en) | 1999-09-28 | 2001-04-04 | Applied Research Systems ARS Holding N.V. | Pharmaceutically active sulfonyl amino acid derivatives |
| US20020115689A1 (en) | 1999-12-21 | 2002-08-22 | Joanne Waldstreicher | Combination therapy for treating neurodegenerative disease |
| EP1110957A1 (en) * | 1999-12-24 | 2001-06-27 | Applied Research Systems ARS Holding N.V. | Benzazole derivatives and their use as JNK modulators |
| WO2001062959A2 (en) * | 2000-02-25 | 2001-08-30 | Metriogene Biosciences Inc. | Endometriosis-related markers and uses thereof |
| EP1193267A1 (en) | 2000-09-27 | 2002-04-03 | Applied Research Systems ARS Holding N.V. | Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein JunKinases |
| EP1193268A1 (en) | 2000-09-27 | 2002-04-03 | Applied Research Systems ARS Holding N.V. | Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein Junkinases |
| US6399626B1 (en) | 2000-10-02 | 2002-06-04 | Wyeth | Hydroxyesters of 7-desmethylrapamycin |
| US20030134836A1 (en) * | 2001-01-12 | 2003-07-17 | Amgen Inc. | Substituted arylamine derivatives and methods of use |
| US7115617B2 (en) | 2001-08-22 | 2006-10-03 | Amgen Inc. | Amino-substituted pyrimidinyl derivatives and methods of use |
| PT1450792E (pt) | 2001-12-07 | 2006-12-29 | Applied Research Systems | Derivados de benzazole para o tratamento de esclerodermia |
| US7635681B2 (en) * | 2002-01-09 | 2009-12-22 | Xigen Sa | Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| GB0204159D0 (en) | 2002-02-22 | 2002-04-10 | British Biotech Pharm | Metalloproteinase inhibitors |
| CA2478338A1 (en) * | 2002-03-08 | 2003-09-18 | Signal Pharmaceuticals, Inc. | Combination therapy for treating, preventing or managing proliferative disorders and cancers |
| AU2003233067B2 (en) | 2002-04-25 | 2009-01-08 | Merck Serono Sa | Piperazine benzothiazoles as agents for the treatment of cerebral ischemic disorders or CNS disorders |
| KR20050048642A (ko) | 2002-09-25 | 2005-05-24 | 메이지 세이카 가부시키가이샤 | 서방성 농약 입제 |
| TWI291467B (en) | 2002-11-13 | 2007-12-21 | Millennium Pharm Inc | CCR1 antagonists and methods of use therefor |
| WO2004082665A1 (ja) | 2003-03-17 | 2004-09-30 | Takeda Pharmaceutical Company Limited | 放出制御組成物 |
| AU2004271740B2 (en) | 2003-09-12 | 2010-10-28 | Merck Serono Sa | Benzothiazole derivatives for the treatment of diabetes |
| US20070079629A1 (en) | 2003-10-30 | 2007-04-12 | Laboratories Serono S.A. | Process and apparatus for cooling and atomizing liquid or pasty-like substances |
| RU2253489C1 (ru) * | 2004-04-07 | 2005-06-10 | Научный центр акушерства, гинекологии и перинатологии РАМН | Способ лечения бесплодия у женщин с наружным генитальным эндометриозом |
| US7838522B2 (en) * | 2004-11-17 | 2010-11-23 | Ares Trading S.A. | Benzothiazole formulations and use thereof |
| JP5144271B2 (ja) * | 2004-11-17 | 2013-02-13 | アレス トレーディング ソシエテ アノニム | ベンゾチアゾ−ル製剤、及びそれらの使用 |
-
2006
- 2006-07-11 BR BRPI0613042-9A patent/BRPI0613042A2/pt not_active IP Right Cessation
- 2006-07-12 WO PCT/US2006/027455 patent/WO2007011762A2/en not_active Ceased
- 2006-07-12 CA CA002611598A patent/CA2611598A1/en not_active Abandoned
- 2006-07-12 AU AU2006270184A patent/AU2006270184B2/en not_active Ceased
- 2006-07-12 US US11/988,572 patent/US8592414B2/en not_active Expired - Fee Related
- 2006-07-12 KR KR1020137016652A patent/KR20130087052A/ko not_active Ceased
- 2006-07-12 EP EP06787369A patent/EP1904181A2/en not_active Withdrawn
- 2006-07-12 SG SG201006416-0A patent/SG165343A1/en unknown
- 2006-07-12 MX MX2008000663A patent/MX2008000663A/es active IP Right Grant
- 2006-07-12 JP JP2008521654A patent/JP2009509916A/ja not_active Withdrawn
- 2006-07-12 EA EA200800343A patent/EA016437B1/ru not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2611598A1 (en) | 2007-01-25 |
| AU2006270184A1 (en) | 2007-01-25 |
| WO2007011762A3 (en) | 2007-04-05 |
| EP1904181A2 (en) | 2008-04-02 |
| WO2007011762A2 (en) | 2007-01-25 |
| US8592414B2 (en) | 2013-11-26 |
| EA200800343A1 (ru) | 2008-06-30 |
| BRPI0613042A2 (pt) | 2010-12-14 |
| JP2009509916A (ja) | 2009-03-12 |
| KR20130087052A (ko) | 2013-08-05 |
| US20090176761A1 (en) | 2009-07-09 |
| AU2006270184B2 (en) | 2011-09-29 |
| EA016437B1 (ru) | 2012-05-30 |
| WO2007011762A8 (en) | 2007-08-02 |
| MX2008000663A (es) | 2008-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200800755A1 (ru) | Ikk ингибиторы, предназначенные для лечения эндометриоза | |
| MY150697A (en) | Methods of treating cancer using pyridopyrimdinone inhibitors of p13k alpha | |
| JO2886B1 (en) | Useful compounds in the inhibition of CHK1 | |
| MX366119B (es) | Uso de un agente inhibidor de masp-2 para el tratamiento de condiciones renales mediadas por complemento dependiente de la masp-2. | |
| MY150797A (en) | Combination therapies comprising quinaxoline inhibitors of pi3k-alpha for use in the treatment of cancer | |
| MY153669A (en) | Ocular allergy treatments field of the invention | |
| TN2010000209A1 (en) | Treatment of uterine cancer and ovarian cancer with a parp inhibitor alone or in combination with anti-tumor agents | |
| TW200605886A (en) | Indazoles useful in treating cardiovascular diseases | |
| MX2008011633A (es) | Aminoquinolonas como inhibidores de gsk-3. | |
| MX2008011872A (es) | Analogos de tiazolidinediona para el tratamiento de la hipertension y para disminuir lipidos. | |
| MX2010004967A (es) | Uso de inhibidor de cfms para el tratamiento y la prevención del cancer de hueso, así como la perdida osea y el dolor de hueso asociados con el cancer de hueso. | |
| TW200733976A (en) | Method for the treatment of cognitive dysfunction | |
| MXPA05011501A (es) | Combinacion terapeutica de un inhibidor de cox-2 y un inhibidor de aromatasa. | |
| WO2007030360A3 (en) | P13k inhibitors for the treatment of endometriosis | |
| WO2007097980A3 (en) | Ubiquitin/proteasome inhibitors for the treatment of spinal muscular atrophy | |
| TW200730190A (en) | New combination to treat liver fibrosis | |
| WO2009148600A3 (en) | Deuterated lysine-based compounds | |
| UA96736C2 (ru) | Ингибиторы pi3k для лечения эндометриоза | |
| SG165343A1 (en) | Jnk inhibitors for the treatment of endometriosis | |
| WO2008063853A3 (en) | Cancer treatment method | |
| ZA200710497B (en) | Glepp-1 inhibitors in the treatment of autoimmune and/or inflammatory disorders | |
| TW200642688A (en) | New use of PDE7 inhibitors | |
| UA89242C2 (ru) | Способ лечения эндометриоза с применением ингибитора jnk, которым является производное бензотиазола | |
| NO20080782L (no) | JNK-inhibitorer for behandling av endometriose | |
| TW200603792A (en) | Monotherapy for the treatment of psoriasis with cyclooxygenase-2 selective inhibitors |